Wildcat Capital Management, LLC Quant / Systematic

Location: New York, NY

CIK: 0001582384 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Jan 29, 2025

Total Value: $253M (100.0% shares, 0.0% debt)

Holdings (8)

ULCC FRONTIER GROUP HLDGS INC 79.0%

Value $200M Shares 28,061,351 Share Price $7.11 Est. Cost/Share $5.99 Unrealized @ Report Date +18.6%

RLX RLX TECHNOLOGY INC 15.4%

Value $38.98M Shares 18,046,195 Share Price $2.16 Est. Cost/Share $5.25 Unrealized @ Report Date -58.8%

ALLO ALLOGENE THERAPEUTICS INC 2.5%

Value $6.221M Shares 2,920,787 Share Price $2.13 Est. Cost/Share $17.44 Unrealized @ Report Date -87.8%

URGN UROGEN PHARMA LTD 2.1%

Value $5.278M Shares 495,606 Share Price $10.65 Est. Cost/Share $34.01 Unrealized @ Report Date -68.7%

— KRONOS BIO INC 0.5%

Value $1.233M Shares 1,297,959 Share Price $0.95 Est. Cost/Share $29.87 Unrealized @ Report Date —

GTLB GITLAB INC 0.3%

Value $642K Shares 11,399 Share Price $56.35 Est. Cost/Share $58.30 Unrealized @ Report Date -3.3%

PCOR PROCORE TECHNOLOGIES INC 0.2%

Value $607K Shares 8,095 Share Price $74.93 Est. Cost/Share $70.94 Unrealized @ Report Date +5.6%

— SILEXION THERAPEUTICS CORP 0.1%

Value $228K Shares 113,428 Share Price $2.01 Est. Cost/Share $2.01 Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
ULCC	FRONTIER GROUP HLDGS INC	28,061,351	$200M	79.0%	$7.11	$5.99	+18.6%	COM	35909R108
RLX	RLX TECHNOLOGY INC	18,046,195	$38.98M	15.4%	$2.16	$5.25	-58.8%	SPONSORED ADS	74969N103
ALLO	ALLOGENE THERAPEUTICS INC	2,920,787	$6.221M	2.5%	$2.13	$17.44	-87.8%	COM	019770106
URGN	UROGEN PHARMA LTD	495,606	$5.278M	2.1%	$10.65	$34.01	-68.7%	COM	M96088105
—	KRONOS BIO INC	1,297,959	$1.233M	0.5%	$0.95	$29.87	—	COM	50107A104
GTLB	GITLAB INC	11,399	$642K	0.3%	$56.35	$58.30	-3.3%	CLASS A COM	37637K108
PCOR	PROCORE TECHNOLOGIES INC	8,095	$607K	0.2%	$74.93	$70.94	+5.6%	COM	74275K108
—	SILEXION THERAPEUTICS CORP	113,428	$228K	0.1%	$2.01	$2.01	—	SHS NEW	G1281K122